Quantbot Technologies’s Cerevel Therapeutics Holdings CERE Stock Holding History
Bought
Maintained
Sold
Other funds holding CERE
Quantbot Technologies's CERE Position: Q1 2023 in Review
Quantbot Technologies sold out of Cerevel Therapeutics Holdings (CERE) in Q1 2023, closing a stake of 8,647 shares — an estimated $273K sold.
Quantbot Technologies first reported a position in CERE in Q3 2021 and held it in 3 quarters. The position peaked at $273K in Q4 2022. 119 funds tracked by Wall St. Rank hold CERE as of Q1 2023.
- Quantbot Technologies reported no remaining Cerevel Therapeutics Holdings position as of Q1 2023 after selling out during the quarter.
- Quantbot Technologies sold 8,647 Cerevel Therapeutics Holdings shares in Q1 2023, an estimated $273K.
- Quantbot Technologies first reported a position in Cerevel Therapeutics Holdings in Q3 2021 and held it in 3 quarters.
- Quantbot Technologies's Cerevel Therapeutics Holdings position peaked at $273K in Q4 2022.
- 119 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings as of Q1 2023.
Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.